scholarly article | Q13442814 |
P50 | author | Ian Ellis | Q55300055 |
P2093 | author name string | Lewis S | |
Elston CW | |||
Blamey RW | |||
Bell JA | |||
Nicholson R | |||
Todd JH | |||
Locker A | |||
P2860 | cites work | Human epidermal growth factor: isolation and chemical and biological properties | Q35075356 |
Breast cancer and a proto-oncogene | Q35718067 | ||
Confirmation of a prognostic index in primary breast cancer. | Q36028322 | ||
Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer | Q37195907 | ||
Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesis | Q37531550 | ||
Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma | Q39761350 | ||
Growth requirements of human mammary epithelial cells in culture | Q40664330 | ||
Estrogen receptor assay in primary breast cancer and early recurrence of the disease | Q43975464 | ||
Prognostic factors in breast cancer -- the formation of a prognostic index | Q66958131 | ||
Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer | Q69856765 | ||
Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer | Q69900051 | ||
Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer | Q70046632 | ||
Epidermal growth factor stimulation of human breast cancer cells in culture | Q72076778 | ||
Cellular localisation of human epidermal growth factor receptor | Q72392851 | ||
Receptor Binding and Processing of Epidermal Growth Factor by Human Breast Cancer Cells* | Q72929970 | ||
Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal | Q79368389 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 385-389 | |
P577 | publication date | 1990-05-01 | |
P1433 | published in | Journal of Clinical Pathology | Q6294965 |
P1476 | title | Expression of epidermal growth factor receptor in breast carcinoma | |
P478 | volume | 43 |
Q71635509 | A dual immunocytochemical assay for oestrogen and epidermal growth factor receptors in tumour cell lines |
Q41053705 | A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma |
Q72088667 | An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors |
Q62690657 | Analysis of the genes for oestrogen and epidermal growth factor receptors in human breast cancer |
Q40848953 | Biological indices in the assessment of breast cancer |
Q35017851 | Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells |
Q36194648 | Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study |
Q59487603 | Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival |
Q36537922 | Detection of tumor antigens with monoclonal antibodies: immunopathology and immunodiagnosis |
Q46654519 | Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients |
Q36536905 | Diagnostic utility of oncogenes and their products in human cancer |
Q35979084 | Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer |
Q71702871 | Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors |
Q70779513 | Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study |
Q44438798 | Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy. |
Q68132983 | Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology |
Q37970020 | ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective |
Q44588191 | Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). |
Q36696088 | Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma |
Q36115645 | Expression of c-erbB3 protein in primary breast carcinomas |
Q35984818 | Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder |
Q36787372 | Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas |
Q43912153 | Fatty acid synthase affects expression of ErbB receptors in epithelial to mesenchymal transition of breast cancer cells and invasive ductal carcinoma |
Q35228457 | Hormone receptors in malignancy |
Q67491834 | Immunocytochemistry and in situ hybridisation of epidermal growth factor receptor and relation to prognostic factors in breast cancer |
Q35993833 | Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening |
Q36081088 | Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer |
Q35993847 | Influence of the antioestrogen tamoxifen on normal breast tissue |
Q62690642 | Investigation of the mechanisms determining the inverse relationship between oestrogen and epidermal growth factor receptors in primary human breast cancer |
Q34987420 | Molecular alterations in sporadic breast cancer |
Q72859996 | Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer |
Q41648567 | Prognostic and response markers in the management of breast cancer |
Q40657286 | Prognostic factors in early breast carcinoma. |
Q44845527 | Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer |
Q41679383 | Protein tyrosine kinases and cancer |
Q35233707 | Radish (Raphanus sativus L. leaf) ethanol extract inhibits protein and mRNA expression of ErbB(2) and ErbB(3) in MDA-MB-231 human breast cancer cells |
Q54419333 | Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity. |
Q35992905 | Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer |
Q35993921 | Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases |
Q45234395 | Significance of epidermal growth factor receptor expression in breast cancer |
Q35983341 | The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer |
Q40665439 | The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients |
Q33959323 | The epidermal growth factor receptor in breast cancer. |
Q78677643 | The invasive phenotype in HMT-3522 cells requires increased EGF receptor signaling through both PI 3-kinase and ERK 1,2 pathways |
Q43788104 | The prognostic significance of epidermal growth factor receptor expression in breast cancer |
Q35976972 | The prognostic significance of transforming growth factors in human breast cancer |
Q33538455 | The relationship between prognostic and predictive factors in the management of breast cancer |
Q35994620 | Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer |
Q36621288 | c-erbB-4 protein expression in human breast cancer |
Search more.